Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Bolis

Showing results (31-40 of 129) with videos related to

Pageof 13
Sort By:
Chemical Physics Letters|August 24, 1984
Potential-derived point-charge model study of electrostatic interactions in DNA base componentsN K Ray, M Shibata, G Bolis, et al.
Clinical and Experimental Immunology|September 1, 1982
Antibody-dependent and -independent cytotoxicity of human mononuclear phagocytes: defective stimulation of tumoricidal activity in milk macrophagesA Biondi, G Peri, N Colombo, et al.
Annali Di Ostetricia, Ginecologia, Medicina Perinatale|March 1, 1981
[Incidence and prognostic significance of recurrence hydatidiform mole]G Bolis, C Belloni, I Valente, et al.
British Journal of Cancer|February 12, 1998
Survival and prognostic factors of early ovarian cancerA Villa, F Parazzini, S Acerboni, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 1995
Survival of advanced ovarian cancer patients with microscopic partial response after surgery and first-line chemotherapyG Bolis, A Villa, C Ferraris, et al.
European Journal of Cancer|August 1, 1977
Melphalan vs polymelphalanum in ovarian cancer patients resistant to cyclophosphamide: a tentative statistical approach to balance risks and benefitsL Morasca, M Recchia, E Gramellini, et al.
Cancer Treatment Reports|December 1, 1978
Variable oral absorption of hexamethylmelamine in manM D'Incalci, G Bolis, C Mangioni, et al.
European Journal of Drug Metabolism and Pharmacokinetics|January 1, 1979
Pharmacokinetics of cyclophosphamide after prolonged low dose treatment in ovarian cancer patientsM D'Incalci, T Facchinetti, G Bolis, et al.
British Journal of Cancer|January 15, 1999
Survival and determinants of response to third-line chemotherapy in sensitive recurrent ovarian cancer patientsA Villa, F Parazzini, G Scarfone, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale|October 15, 1982
[Effect of the ionophore A 23187 + Ca++ on erythrocytes of marine vertebrates]D Marino, T M Marino, D Altavilla, et al.
Pageof 13

Showing results (31-40 of 129) with videos related to

Sort By:
Pageof 13
Chemical Physics Letters|August 24, 1984
Potential-derived point-charge model study of electrostatic interactions in DNA base componentsN K Ray, M Shibata, G Bolis, et al.
Clinical and Experimental Immunology|September 1, 1982
Antibody-dependent and -independent cytotoxicity of human mononuclear phagocytes: defective stimulation of tumoricidal activity in milk macrophagesA Biondi, G Peri, N Colombo, et al.
Annali Di Ostetricia, Ginecologia, Medicina Perinatale|March 1, 1981
[Incidence and prognostic significance of recurrence hydatidiform mole]G Bolis, C Belloni, I Valente, et al.
British Journal of Cancer|February 12, 1998
Survival and prognostic factors of early ovarian cancerA Villa, F Parazzini, S Acerboni, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 1995
Survival of advanced ovarian cancer patients with microscopic partial response after surgery and first-line chemotherapyG Bolis, A Villa, C Ferraris, et al.
European Journal of Cancer|August 1, 1977
Melphalan vs polymelphalanum in ovarian cancer patients resistant to cyclophosphamide: a tentative statistical approach to balance risks and benefitsL Morasca, M Recchia, E Gramellini, et al.
Cancer Treatment Reports|December 1, 1978
Variable oral absorption of hexamethylmelamine in manM D'Incalci, G Bolis, C Mangioni, et al.
European Journal of Drug Metabolism and Pharmacokinetics|January 1, 1979
Pharmacokinetics of cyclophosphamide after prolonged low dose treatment in ovarian cancer patientsM D'Incalci, T Facchinetti, G Bolis, et al.
British Journal of Cancer|January 15, 1999
Survival and determinants of response to third-line chemotherapy in sensitive recurrent ovarian cancer patientsA Villa, F Parazzini, G Scarfone, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale|October 15, 1982
[Effect of the ionophore A 23187 + Ca++ on erythrocytes of marine vertebrates]D Marino, T M Marino, D Altavilla, et al.
Pageof 13